Logo image of PDYN

PALLADYNE AI CORP (PDYN) Stock Fundamental Analysis

NASDAQ:PDYN - Nasdaq - US80359A2050 - Common Stock - Currency: USD

8.91  +0.33 (+3.85%)

After market: 8.89 -0.02 (-0.22%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to PDYN. PDYN was compared to 128 industry peers in the Machinery industry. No worries on liquidiy or solvency for PDYN as it has an excellent financial health rating, but there are worries on the profitability. PDYN is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year PDYN has reported negative net income.
PDYN had a negative operating cash flow in the past year.
PDYN Yearly Net Income VS EBIT VS OCF VS FCFPDYN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 -50M -100M -150M

1.2 Ratios

PDYN's Return On Assets of -67.34% is on the low side compared to the rest of the industry. PDYN is outperformed by 91.41% of its industry peers.
With a Return On Equity value of -150.64%, PDYN is not doing good in the industry: 87.50% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -67.34%
ROE -150.64%
ROIC N/A
ROA(3y)-138.04%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PDYN Yearly ROA, ROE, ROICPDYN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 200 -200 400 600

1.3 Margins

PDYN's Gross Margin of 67.71% is amongst the best of the industry. PDYN outperforms 99.22% of its industry peers.
PDYN's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for PDYN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 67.71%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y32.37%
GM growth 5YN/A
PDYN Yearly Profit, Operating, Gross MarginsPDYN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 -500 -1K -1.5K

7

2. Health

2.1 Basic Checks

PDYN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, PDYN has more shares outstanding
PDYN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
PDYN Yearly Shares OutstandingPDYN Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 10M 20M 30M
PDYN Yearly Total Debt VS Total AssetsPDYN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

Based on the Altman-Z score of -5.30, we must say that PDYN is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -5.30, PDYN is not doing good in the industry: 91.41% of the companies in the same industry are doing better.
PDYN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -5.3
ROIC/WACCN/A
WACC10.07%
PDYN Yearly LT Debt VS Equity VS FCFPDYN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 50M -50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 16.03 indicates that PDYN has no problem at all paying its short term obligations.
With an excellent Current ratio value of 16.03, PDYN belongs to the best of the industry, outperforming 97.66% of the companies in the same industry.
A Quick Ratio of 16.00 indicates that PDYN has no problem at all paying its short term obligations.
PDYN has a better Quick ratio (16.00) than 97.66% of its industry peers.
Industry RankSector Rank
Current Ratio 16.03
Quick Ratio 16
PDYN Yearly Current Assets VS Current LiabilitesPDYN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 50M 100M 150M 200M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 55.83% over the past year.
The Revenue for PDYN has decreased by -16.95% in the past year. This is quite bad
The Revenue has been growing by 15.33% on average over the past years. This is quite good.
EPS 1Y (TTM)55.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%42.86%
Revenue 1Y (TTM)-16.95%
Revenue growth 3Y15.33%
Revenue growth 5YN/A
Sales Q2Q%-50.29%

3.2 Future

Based on estimates for the next years, PDYN will show a quite strong growth in Earnings Per Share. The EPS will grow by 17.31% on average per year.
Based on estimates for the next years, PDYN will show a very strong growth in Revenue. The Revenue will grow by 21.50% on average per year.
EPS Next Y23.76%
EPS Next 2Y17.31%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-25.27%
Revenue Next 2Y21.5%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
PDYN Yearly Revenue VS EstimatesPDYN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 5M 10M
PDYN Yearly EPS VS EstimatesPDYN Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 -1 -2 -3

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for PDYN. In the last year negative earnings were reported.
Also next year PDYN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PDYN Price Earnings VS Forward Price EarningsPDYN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PDYN Per share dataPDYN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 -1 -1.5

4.3 Compensation for Growth

PDYN's earnings are expected to grow with 17.31% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y17.31%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for PDYN!.
Industry RankSector Rank
Dividend Yield N/A

PALLADYNE AI CORP

NASDAQ:PDYN (6/18/2025, 8:18:21 PM)

After market: 8.89 -0.02 (-0.22%)

8.91

+0.33 (+3.85%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)08-05 2025-08-05
Inst Owners12.29%
Inst Owner ChangeN/A
Ins Owners22.78%
Ins Owner Change-1.97%
Market Cap318.18M
Analysts82.86
Price Target15.3 (71.72%)
Short Float %11.39%
Short Ratio1.44
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-304.99%
Min EPS beat(2)-635.29%
Max EPS beat(2)25.3%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-2%
Min Revenue beat(2)-43.71%
Max Revenue beat(2)39.71%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-9.73%
Revenue NY rev (1m)0%
Revenue NY rev (3m)4.12%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 52.55
P/FCF N/A
P/OCF N/A
P/B 11.24
P/tB 11.24
EV/EBITDA N/A
EPS(TTM)-1.74
EYN/A
EPS(NY)-0.64
Fwd EYN/A
FCF(TTM)-0.65
FCFYN/A
OCF(TTM)-0.64
OCFYN/A
SpS0.17
BVpS0.79
TBVpS0.79
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -67.34%
ROE -150.64%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 67.71%
FCFM N/A
ROA(3y)-138.04%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y32.37%
GM growth 5YN/A
F-Score5
Asset Turnover0.1
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 34.95%
Cap/Sales 4.89%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 16.03
Quick Ratio 16
Altman-Z -5.3
F-Score5
WACC10.07%
ROIC/WACCN/A
Cap/Depr(3y)30.56%
Cap/Depr(5y)N/A
Cap/Sales(3y)8.8%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)55.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%42.86%
EPS Next Y23.76%
EPS Next 2Y17.31%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-16.95%
Revenue growth 3Y15.33%
Revenue growth 5YN/A
Sales Q2Q%-50.29%
Revenue Next Year-25.27%
Revenue Next 2Y21.5%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y60.09%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year13.54%
EBIT Next 3Y90.23%
EBIT Next 5Y65.6%
FCF growth 1Y70.42%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y70.47%
OCF growth 3YN/A
OCF growth 5YN/A